PHARMACEUTICAL COMPOSITION CONTAINING HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY
To provide a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody suitable for administration to a subject.SOLUTION: The present invention provides a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody as an active ingredient, the pharmaceutical compo...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TANIMOTO MASAHIKO MORI NAOKI SAITO HIROSHI IKEMOTO KEISUKE |
| description | To provide a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody suitable for administration to a subject.SOLUTION: The present invention provides a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody as an active ingredient, the pharmaceutical composition containing essentially no sodium chloride or less than 30 mM sodium chloride. The present invention also provides a freeze-drying agent of the pharmaceutical composition.SELECTED DRAWING: Figure 2
【課題】本発明の目的は、対象への投与に適した、ヒト抗ＩＬ－３３モノクローナル抗体を含有する医薬用組成物を提供することである。【解決手段】本発明は、ヒト抗ＩＬ－３３モノクローナル抗体を有効成分として含有する医薬用組成物であって、塩化ナトリウムを本質的に含有しない、または、３０ｍＭ未満の塩化ナトリウムを含有する、医薬用組成物を提供する。また、本発明は、前記医薬用組成物の凍結乾燥剤を提供する。【選択図】図２ |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2023182736A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2023182736A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2023182736A3</originalsourceid><addsrcrecordid>eNrjZPAK8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wOy_UIcPf08_dwVPEJ9Hf0UHP1CPHU9fXSNjRV8_f38nX38_YBaQKJO_i6RPAysaYk5xam8UJqbQcnNNcTZQze1ID8-tbggMTk1L7Uk3ivAyMDI2NDCyNzYzNGYKEUAzEst8A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION CONTAINING HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY</title><source>esp@cenet</source><creator>TANIMOTO MASAHIKO ; MORI NAOKI ; SAITO HIROSHI ; IKEMOTO KEISUKE</creator><creatorcontrib>TANIMOTO MASAHIKO ; MORI NAOKI ; SAITO HIROSHI ; IKEMOTO KEISUKE</creatorcontrib><description>To provide a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody suitable for administration to a subject.SOLUTION: The present invention provides a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody as an active ingredient, the pharmaceutical composition containing essentially no sodium chloride or less than 30 mM sodium chloride. The present invention also provides a freeze-drying agent of the pharmaceutical composition.SELECTED DRAWING: Figure 2
【課題】本発明の目的は、対象への投与に適した、ヒト抗ＩＬ－３３モノクローナル抗体を含有する医薬用組成物を提供することである。【解決手段】本発明は、ヒト抗ＩＬ－３３モノクローナル抗体を有効成分として含有する医薬用組成物であって、塩化ナトリウムを本質的に含有しない、または、３０ｍＭ未満の塩化ナトリウムを含有する、医薬用組成物を提供する。また、本発明は、前記医薬用組成物の凍結乾燥剤を提供する。【選択図】図２</description><language>eng ; jpn</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231226&DB=EPODOC&CC=JP&NR=2023182736A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231226&DB=EPODOC&CC=JP&NR=2023182736A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TANIMOTO MASAHIKO</creatorcontrib><creatorcontrib>MORI NAOKI</creatorcontrib><creatorcontrib>SAITO HIROSHI</creatorcontrib><creatorcontrib>IKEMOTO KEISUKE</creatorcontrib><title>PHARMACEUTICAL COMPOSITION CONTAINING HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY</title><description>To provide a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody suitable for administration to a subject.SOLUTION: The present invention provides a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody as an active ingredient, the pharmaceutical composition containing essentially no sodium chloride or less than 30 mM sodium chloride. The present invention also provides a freeze-drying agent of the pharmaceutical composition.SELECTED DRAWING: Figure 2
【課題】本発明の目的は、対象への投与に適した、ヒト抗ＩＬ－３３モノクローナル抗体を含有する医薬用組成物を提供することである。【解決手段】本発明は、ヒト抗ＩＬ－３３モノクローナル抗体を有効成分として含有する医薬用組成物であって、塩化ナトリウムを本質的に含有しない、または、３０ｍＭ未満の塩化ナトリウムを含有する、医薬用組成物を提供する。また、本発明は、前記医薬用組成物の凍結乾燥剤を提供する。【選択図】図２</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPAK8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wOy_UIcPf08_dwVPEJ9Hf0UHP1CPHU9fXSNjRV8_f38nX38_YBaQKJO_i6RPAysaYk5xam8UJqbQcnNNcTZQze1ID8-tbggMTk1L7Uk3ivAyMDI2NDCyNzYzNGYKEUAzEst8A</recordid><startdate>20231226</startdate><enddate>20231226</enddate><creator>TANIMOTO MASAHIKO</creator><creator>MORI NAOKI</creator><creator>SAITO HIROSHI</creator><creator>IKEMOTO KEISUKE</creator><scope>EVB</scope></search><sort><creationdate>20231226</creationdate><title>PHARMACEUTICAL COMPOSITION CONTAINING HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY</title><author>TANIMOTO MASAHIKO ; MORI NAOKI ; SAITO HIROSHI ; IKEMOTO KEISUKE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2023182736A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TANIMOTO MASAHIKO</creatorcontrib><creatorcontrib>MORI NAOKI</creatorcontrib><creatorcontrib>SAITO HIROSHI</creatorcontrib><creatorcontrib>IKEMOTO KEISUKE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TANIMOTO MASAHIKO</au><au>MORI NAOKI</au><au>SAITO HIROSHI</au><au>IKEMOTO KEISUKE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION CONTAINING HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY</title><date>2023-12-26</date><risdate>2023</risdate><abstract>To provide a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody suitable for administration to a subject.SOLUTION: The present invention provides a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody as an active ingredient, the pharmaceutical composition containing essentially no sodium chloride or less than 30 mM sodium chloride. The present invention also provides a freeze-drying agent of the pharmaceutical composition.SELECTED DRAWING: Figure 2
【課題】本発明の目的は、対象への投与に適した、ヒト抗ＩＬ－３３モノクローナル抗体を含有する医薬用組成物を提供することである。【解決手段】本発明は、ヒト抗ＩＬ－３３モノクローナル抗体を有効成分として含有する医薬用組成物であって、塩化ナトリウムを本質的に含有しない、または、３０ｍＭ未満の塩化ナトリウムを含有する、医薬用組成物を提供する。また、本発明は、前記医薬用組成物の凍結乾燥剤を提供する。【選択図】図２</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2023182736A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PHARMACEUTICAL COMPOSITION CONTAINING HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T02%3A01%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TANIMOTO%20MASAHIKO&rft.date=2023-12-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2023182736A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |